A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC

NCT07193641 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

RADIATION: Spatially Fractionated Radiotherapy (SFRT)+Stereotactic Body Radiation Therapy (SBRT)
DRUG: The systemic therapy

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University